Literature DB >> 24889436

An official American Thoracic Society/American College of Chest Physicians policy statement: the Choosing Wisely top five list in adult pulmonary medicine.

Renda Soylemez Wiener1, Daniel R Ouellette2, Edward Diamond3, Vincent S Fan4, Janet R Maurer5, Richard A Mularski6, Jay I Peters7, Scott D Halpern8.   

Abstract

The American Board of Internal Medicine Foundation's Choosing Wisely campaign aims to curb health-care costs and improve patient care by soliciting lists from medical societies of the top five tests or treatments in their specialty that are used too frequently and inappropriately. The American Thoracic Society (ATS) and American College of Chest Physicians created a joint task force, which produced a top five list for adult pulmonary medicine. Our top five recommendations, which were approved by the executive committees of the ATS and American College of Chest Physicians and published by Choosing Wisely in October 2013, are as follows: (1) Do not perform CT scan surveillance for evaluation of indeterminate pulmonary nodules at more frequent intervals or for a longer period of time than recommended by established guidelines; (2) do not routinely offer pharmacologic treatment with advanced vasoactive agents approved only for the management of pulmonary arterial hypertension to patients with pulmonary hypertension resulting from left heart disease or hypoxemic lung diseases (groups II or III pulmonary hypertension); (3) for patients recently discharged on supplemental home oxygen following hospitalization for an acute illness, do not renew the prescription without assessing the patient for ongoing hypoxemia; (4) do not perform chest CT angiography to evaluate for possible pulmonary embolism in patients with a low clinical probability and negative results of a highly sensitive D-dimer assay; (5) do not perform CT scan screening for lung cancer among patients at low risk for lung cancer. We hope pulmonologists will use these recommendations to stimulate frank discussions with patients about when these tests and treatments are indicated--and when they are not.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24889436      PMCID: PMC4694177          DOI: 10.1378/chest.14-0670

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  75 in total

1.  Pulmonary hypertension surveillance--United States, 1980-2002.

Authors:  Alexandra Hyduk; Janet B Croft; Carma Ayala; Kan Zheng; Zhi-Jie Zheng; George A Mensah
Journal:  MMWR Surveill Summ       Date:  2005-11-11

2.  What the heck is a "nodule"? A qualitative study of veterans with pulmonary nodules.

Authors:  Christopher G Slatore; Nancy Press; David H Au; J Randall Curtis; Renda Soylemez Wiener; Linda Ganzini
Journal:  Ann Am Thorac Soc       Date:  2013-08

3.  A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

Authors:  R M Califf; K F Adams; W J McKenna; M Gheorghiade; B F Uretsky; S E McNulty; H Darius; K Schulman; F Zannad; E Handberg-Thurmond; F E Harrell; W Wheeler; J Soler-Soler; K Swedberg
Journal:  Am Heart J       Date:  1997-07       Impact factor: 4.749

4.  The prevalence of clinically relevant incidental findings on chest computed tomographic angiograms ordered to diagnose pulmonary embolism.

Authors:  William B Hall; Sherstin G Truitt; Leslie P Scheunemann; Sidharth A Shah; M Patricia Rivera; Leonard A Parker; Shannon S Carson
Journal:  Arch Intern Med       Date:  2009-11-23

5.  Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

Authors:  Margaret M Redfield; Horng H Chen; Barry A Borlaug; Marc J Semigran; Kerry L Lee; Gregory Lewis; Martin M LeWinter; Jean L Rouleau; David A Bull; Douglas L Mann; Anita Deswal; Lynne W Stevenson; Michael M Givertz; Elizabeth O Ofili; Christopher M O'Connor; G Michael Felker; Steven R Goldsmith; Bradley A Bart; Steven E McNulty; Jenny C Ibarra; Grace Lin; Jae K Oh; Manesh R Patel; Raymond J Kim; Russell P Tracy; Eric J Velazquez; Kevin J Anstrom; Adrian F Hernandez; Alice M Mascette; Eugene Braunwald
Journal:  JAMA       Date:  2013-03-27       Impact factor: 56.272

6.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

Review 7.  Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Frank C Detterbeck; Peter J Mazzone; David P Naidich; Peter B Bach
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

8.  Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC).

Authors:  Adam Torbicki; Arnaud Perrier; Stavros Konstantinides; Giancarlo Agnelli; Nazzareno Galiè; Piotr Pruszczyk; Frank Bengel; Adrian J B Brady; Daniel Ferreira; Uwe Janssens; Walter Klepetko; Eckhard Mayer; Martine Remy-Jardin; Jean-Pierre Bassand
Journal:  Eur Heart J       Date:  2008-08-30       Impact factor: 29.983

Review 9.  The inappropriate use of imaging studies: a report of the 2004 Intersociety Conference.

Authors:  N Reed Dunnick; Kimberly E Applegate; Ronald L Arenson
Journal:  J Am Coll Radiol       Date:  2005-05       Impact factor: 5.532

10.  Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study.

Authors:  Ariel Berger; John Edelsberg; Simon Teal; Marko A Mychaskiw; Gerry Oster
Journal:  BMC Pulm Med       Date:  2012-12-11       Impact factor: 3.317

View more
  20 in total

1.  Extolling "palliative radiology" in the frail and elderly: each drop makes an ocean!

Authors:  A Arora
Journal:  Br J Radiol       Date:  2015-04-20       Impact factor: 3.039

2.  Rapid method for direct identification of positive blood cultures by MALDI-TOF MS.

Authors:  Yueling Wang; Yan Jin; Yuanyuan Bai; Zhen Song; Wenjun Chu; Mengqi Zhao; Yingying Hao; Zhiming Lu
Journal:  Exp Ther Med       Date:  2020-10-16       Impact factor: 2.447

3.  Five common errors to avoid in clinical practice: the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) Choosing Wisely Campaign.

Authors:  Elisa Stasi; Andrea Michielan; Gaetano Cristian Morreale; Alessandro Tozzi; Ludovica Venezia; Francesco Bortoluzzi; Omero Triossi; Marco Soncini; Gioacchino Leandro; Giuseppe Milazzo; Andrea Anderloni
Journal:  Intern Emerg Med       Date:  2018-11-29       Impact factor: 3.397

4.  Pulmonary embolism response teams.

Authors:  Nosheen Reza; David M Dudzinski
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-06

5.  An Evaluation of Guideline-Discordant Ordering Behavior for CT Pulmonary Angiography in the Emergency Department.

Authors:  Emma Simon; Isomi M Miake-Lye; Silas W Smith; Jordan L Swartz; Leora I Horwitz; Danil V Makarov; Soterios Gyftopoulos
Journal:  J Am Coll Radiol       Date:  2019-04-29       Impact factor: 5.532

6.  An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice.

Authors:  Renda Soylemez Wiener; Michael K Gould; Douglas A Arenberg; David H Au; Kathleen Fennig; Carla R Lamb; Peter J Mazzone; David E Midthun; Maryann Napoli; David E Ost; Charles A Powell; M Patricia Rivera; Christopher G Slatore; Nichole T Tanner; Anil Vachani; Juan P Wisnivesky; Sue H Yoon
Journal:  Am J Respir Crit Care Med       Date:  2015-10-01       Impact factor: 21.405

Review 7.  Eligibility for home oxygen programs and funding across Canada.

Authors:  Yves Lacasse; Sarah Bernard; François Maltais
Journal:  Can Respir J       Date:  2015-08-25       Impact factor: 2.409

8.  Factors Associated With Potentially Inappropriate Phosphodiesterase-5 Inhibitor Use for Pulmonary Hypertension in the United States, 2006 to 2015.

Authors:  Kari R Gillmeyer; Seppo T Rinne; Mark E Glickman; Kyung Min Lee; Qing Shao; Shirley X Qian; Elizabeth S Klings; Bradley A Maron; Joseph T Hanlon; Donald R Miller; Renda Soylemez Wiener
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-05-12

9.  Qualitative Study to Understand Ordering of CT Angiography to Diagnose Pulmonary Embolism in the Emergency Room Setting.

Authors:  Soterios Gyftopoulos; Silas W Smith; Emma Simon; Masha Kuznetsova; Leora I Horwitz; Danil V Makarov
Journal:  J Am Coll Radiol       Date:  2017-10-19       Impact factor: 5.532

10.  Reassessment of Home Oxygen Prescription after Hospitalization for Chronic Obstructive Pulmonary Disease. A Potential Target for Deimplementation.

Authors:  Laura J Spece; Eric M Epler; Kevin Duan; Lucas M Donovan; Matthew F Griffith; Stephanie LaBedz; Neeta Thakur; Renda Soylemez Wiener; Jerry A Krishnan; David H Au; Laura C Feemster
Journal:  Ann Am Thorac Soc       Date:  2021-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.